The rapid rise of weight loss drugs Wegovy and Mounjaro is generating a host of new product lines as companies hope to land ...
In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy ...
Telehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to Ozempic and Wegovy at a ...
Novo Nordisk A/S NVO is facing a significant challenge in China, where local pharmaceutical companies are developing generic ...
Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...
Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers ...
The Diageo (LSE: DGE) share price is locked in a nasty downtrend at the moment. While the FTSE 100 is rising, it’s going in ...
Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and ...
As the global focus on health and weight management intensifies, Nestle has announced the launch of Vital Pursuit, a brand ...
Semaglutide medications — including Ozempic and Wegovy — have been shown to reduce the risk of kidney failure and the risk of death among people with kidney disease and type 2 diabetes.
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with ... [+] obesity. It should be used with a weight loss plan and physical activity. (Photo by ...